LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Vidaurrazaga, Monica M"
  2. AU="Chen, Jingsi"
  3. AU="Bañon-Maneus, Elisenda"
  4. AU=Small Bryce A.
  5. AU="Sharma, Akash D"
  6. AU="Khan, Aasim"
  7. AU="Clausen, Henrik B"
  8. AU="Makky, Essam A"
  9. AU="Zhu, Chenglou"
  10. AU="Mohammadi, Asma"
  11. AU="Akhtar, Areej"
  12. AU="Reyes, Karen M"
  13. AU="Rose Waswa"
  14. AU="Vahabirad, Mohammad"
  15. AU=Hamam Dana
  16. AU="Textor, Johannes"
  17. AU="Rao, Nanquan"
  18. AU="Monzikova, Anna"
  19. AU="Kulshreshtha, Ritu"
  20. AU="Wilson, Allecia M"
  21. AU="Victorino, Pedro H"
  22. AU="Ban, Sungbea"
  23. AU="Leon-Astudillo, Carmen"
  24. AU=Shrivastav Meena
  25. AU="He, Lingyuan"
  26. AU="Suo, Tao"
  27. AU="Wright, Joseph L"
  28. AU="Sun, Xuegang"
  29. AU="Chien-Wei Su"
  30. AU="Fadipe, Melissa"
  31. AU="Donnelly, Ruairi"

Search results

Result 1 - 5 of total 5

Search options

  1. Article: A case of purulent gonococcal arthritis.

    Vidaurrazaga, Monica M / Perlman, David C

    IDCases

    2019  Volume 19, Page(s) e00662

    Abstract: We present a case of a generally healthy, immunocompetent, 57 year old male on HIV pre-exposure prophylaxis (PrEP) who developed the sudden onset of right wrist pain and swelling with associated left second finger tenosynovitis, due to a disseminated ... ...

    Abstract We present a case of a generally healthy, immunocompetent, 57 year old male on HIV pre-exposure prophylaxis (PrEP) who developed the sudden onset of right wrist pain and swelling with associated left second finger tenosynovitis, due to a disseminated gonococcal infection (DGI) with purulent arthritis. This case's aim is to demonstrate a well-documented but infrequently seen manifestation of
    Language English
    Publishing date 2019-11-05
    Publishing country Netherlands
    Document type Case Reports
    ZDB-ID 2745454-X
    ISSN 2214-2509
    ISSN 2214-2509
    DOI 10.1016/j.idcr.2019.e00662
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Postpartum Fusobacterium gonidiaformans bacteremia.

    Vidaurrazaga, Monica M / McKinley, George F / Camins, Bernard C

    Anaerobe

    2020  Volume 62, Page(s) 102168

    Abstract: We present a case of a healthy 29 year-old female with an uneventful vaginal delivery who had transient, sudden onset of rigors and fever 36 hours postpartum. She was found to have Fusobacterium gonidiaformans bacteremia due to retained placental tissue. ...

    Abstract We present a case of a healthy 29 year-old female with an uneventful vaginal delivery who had transient, sudden onset of rigors and fever 36 hours postpartum. She was found to have Fusobacterium gonidiaformans bacteremia due to retained placental tissue. We report this organism as it is not well-described and rarely reported. It does bear some similarities to other Fusobacterium species that have been reported to cause septicemia in young otherwise healthy patients.
    MeSH term(s) Adult ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Bacteremia/diagnosis ; Bacteremia/microbiology ; Biomarkers ; Blood Culture ; Female ; Fusobacterium/classification ; Fusobacterium/isolation & purification ; Fusobacterium Infections/diagnosis ; Fusobacterium Infections/drug therapy ; Fusobacterium Infections/microbiology ; Humans ; Postpartum Period ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Treatment Outcome
    Chemical Substances Anti-Bacterial Agents ; Biomarkers
    Language English
    Publishing date 2020-01-28
    Publishing country England
    Document type Case Reports
    ZDB-ID 1237621-8
    ISSN 1095-8274 ; 1075-9964
    ISSN (online) 1095-8274
    ISSN 1075-9964
    DOI 10.1016/j.anaerobe.2020.102168
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Postpartum Fusobacterium gonidiaformans bacteremia

    Vidaurrazaga, Monica M / Camins, Bernard C / McKinley, George F

    Anaerobe. 2020 Apr., v. 62

    2020  

    Abstract: We present a case of a healthy 29 year-old female with an uneventful vaginal delivery who had transient, sudden onset of rigors and fever 36 hours postpartum. She was found to have Fusobacterium gonidiaformans bacteremia due to retained placental tissue. ...

    Abstract We present a case of a healthy 29 year-old female with an uneventful vaginal delivery who had transient, sudden onset of rigors and fever 36 hours postpartum. She was found to have Fusobacterium gonidiaformans bacteremia due to retained placental tissue. We report this organism as it is not well-described and rarely reported. It does bear some similarities to other Fusobacterium species that have been reported to cause septicemia in young otherwise healthy patients.
    Keywords animal tissues ; bacteremia ; females ; fever ; Fusobacterium gonidiaformans ; patients ; placenta
    Language English
    Dates of publication 2020-04
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 1237621-8
    ISSN 1075-9964
    ISSN 1075-9964
    DOI 10.1016/j.anaerobe.2020.102168
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center.

    Vawter, Natalie L / Godino, Job G / Lewis, Sydney V / Northrup, Adam W / Samaniego, Jane C / Poblete, Jacqueline Y / Guereca, Jesus A / Sharp, Sydney P / Matthews, Eva / Crespo, Noe C / Lucatero, Pauline G / Vidaurrazaga, Monica M / Ramers, Christian B

    BMC infectious diseases

    2023  Volume 23, Issue 1, Page(s) 105

    Abstract: Background: Monoclonal antibody (mAb) treatment for COVID-19 is associated with improved clinical outcomes. However, there is limited information regarding the impact of treatment on symptoms and the prevalence of post-COVID Conditions (PCC). ... ...

    Abstract Background: Monoclonal antibody (mAb) treatment for COVID-19 is associated with improved clinical outcomes. However, there is limited information regarding the impact of treatment on symptoms and the prevalence of post-COVID Conditions (PCC). Understanding of the association between time to mAb infusion and the development of PCC is also limited.
    Methods: This longitudinal study was conducted among patients with COVID-19 who received mAb infusions at a Federally Qualified Health Center in San Diego, CA. A series of telephone interviews were conducted at baseline and follow-up (14 days and 28+ days). A comprehensive symptom inventory was completed and physical and mental health status were measured using PROMIS-29 and PHQ-2. Pearson's Chi-squared tests and independent two-sample t-tests were performed to test for association between time to mAb infusion and outcomes at follow-up. A Poisson regression model was used to analyze whether time to mAb infusion predicts risk of developing PCC.
    Results: Participants (N = 411) were 53% female, ranged in age from 16 to 92 years (mean 50), and a majority (56%) were Latino/Hispanic. Cross-sectional findings revealed a high symptom burden at baseline (70% of patients had cough, 50% had fever, and 44% had headache). The prevalence of many symptoms decreased substantially by the final follow-up survey (29% of patients had cough, 3% had fever, and 28% had headache). Longitudinal findings indicated that 10 symptoms decreased in prevalence from baseline to final follow-up, 2 remained the same, and 14 increased. The severity of symptoms and most patient-reported physical and mental health measure scores decreased over time. The prevalence of PCC was 69% when PCC was defined as ≥ 1 symptom at final follow-up. Time to mAb infusion was not significantly associated with any outcome at follow-up. Time to infusion was not associated with PCC status at final follow-up in the crude or adjusted Poisson regression models.
    Conclusions: The prevalence of PCC was high among this patient population following COVID-19 mAb treatment. Time to mAb infusion did not predict the development of PCC. Further research in these areas is essential to answer urgent clinical questions about effective treatments of COVID-19.
    MeSH term(s) Humans ; Female ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Male ; COVID-19 ; Post-Acute COVID-19 Syndrome ; Longitudinal Studies ; Cough ; Cross-Sectional Studies ; Headache
    Language English
    Publishing date 2023-02-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041550-3
    ISSN 1471-2334 ; 1471-2334
    ISSN (online) 1471-2334
    ISSN 1471-2334
    DOI 10.1186/s12879-023-08057-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Utility of liquid biopsy in diagnosing isolated cerebral phaeohyphomycosis: illustrative case.

    Arrighi-Allisan, Annie E / Vidaurrazaga, Monica M / De Chavez, Vincent B / Bryce, Clare H / Rutland, John W / Paniz-Mondolfi, Alberto E / Sordillo, Emilia M / Nowak, Michael D / Gitman, Melissa R / Fuller, Risa / Baneman, Emily / Yong, Raymund L

    Journal of neurosurgery. Case lessons

    2022  Volume 3, Issue 5

    Abstract: Background: Cladophialophora bantiana is a dematiaceous, saprophytic fungus and a rare but reported cause of intracranial abscesses due to its strong neurotropism. Although it predominantly affects immunocompetent individuals with environmental exposure, ...

    Abstract Background: Cladophialophora bantiana is a dematiaceous, saprophytic fungus and a rare but reported cause of intracranial abscesses due to its strong neurotropism. Although it predominantly affects immunocompetent individuals with environmental exposure, more recently, its significance as a highly lethal opportunistic infection in transplant recipients has been recognized. Successful treatment requires timely but often challenging diagnosis, followed by complete surgical excision. Next-generation sequencing of microbial cell-free DNA (cfDNA) from plasma is a novel diagnostic method with the potential to identify invasive fungal infections more rapidly and less invasively than conventional microbiological testing, including brain biopsy.
    Observations: The authors described the case of a recipient of a liver transplant who presented with seizures and was found to have innumerable ring-enhancing intracranial lesions. The Karius Test, a commercially available method of next-generation sequencing of cfDNA, was used to determine the causative organism. Samples from the patient's plasma identified C. bantiana 6 days before culture results of the surgical specimen, allowing optimization of the empirical antifungal regimen, which led to a reduction in the size of the abscesses.
    Lessons: The authors' findings suggest that microbial cfDNA sequencing may be particularly impactful in improving the management of brain abscesses in which the differential diagnosis is wide because of immunosuppression.
    Language English
    Publishing date 2022-01-31
    Publishing country United States
    Document type Journal Article
    ISSN 2694-1902
    ISSN (online) 2694-1902
    DOI 10.3171/CASE21557
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top